ATAI LIFE SCIENCES
ATAI is a global biotech company builder that leverages a decentralized, technology- and data-driven platform model to serve millions of people suffering from mental health disorders. The company is committed to acquiring and efficiently developing innovative treatments that address significant unmet medical needs and lead to paradigm shifts in the mental health space. ATAI Life Sciences was founded in 2018 and is based in Munich, Bayern, Germany.
ATAI LIFE SCIENCES
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
522.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Sitelinks Search Box IPv6 Yoast WordPress SEO Plugin ReCAPTCHA
Similar Organizations
ABAC Therapeutics
ABAC Therapeutics (ABAC) develops new targeted antibiotics for patients with severe infections.
AdVita Lifescience
AdVita Lifescience develop effective products and strategies to improve the therapy and diagnosis of rare lung diseases.
Ancilia Biosciences
Ancilia creates innovative bacterial therapeutics that address the microbiome's viral components.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aranda Pharma
Aranda Pharma discovers and develops small molecule drugs to treat diseases of elderly with unmet medical needs.
AudioCure Pharma
AudioCure is dedicated to the development of drug treatments for hearing disorders with a high unmet medical need.
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Braive
Braive develops and delivers online-based Cognitive Behavioural Therapy (CBT) treatment programs for healthcare, businesses and individuals.
Camallergy
Camallergy develops and provides new treatments for common food allergies.
CS Genetics
CS Genetics develops new technology for genomics, based on scientific insights and conceptual innovations in NGS techniques.
Daye
Daye creates category-defining products and services that set a new standard for medical research and scientific innovation.
EnteroBiotix
EnteroBiotix is a developer of novel medicinal products intended to restore health and prevent bacterial infections.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
ExeVir Bio
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.
Fluidic Analytics
Fluidic Analytics designs, develops and manufactures tools that seek to revolutionise the way proteins are characterised.
Iota Sciences
Iota Sciences is develops technologies with unique capabilities to advance discovery into cell biology.
Leyden Labs
Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses.
MiRXES
MiRXES discover, develop, and deliver accurate preventive healthcare solutions.
Mogrify
Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.
Moonai
Healthcare app that uses science-based & personalised sounds to alleviate period pain & beyond
ND BioSciences
ND BioSciences is developing diagnostics and therapies for neurodegenerative diseases.
Neurovalens
Neurovalens delivers innovative solutions in the field of neuroscience, bioscience and neurophysiology
Optibiotix Health
Optibiotix Health discovers and develops microbial strains, compounds and formulations, which modulate the human microbiome.
PreComb Therapeutics AG
PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers.
Sarcura
Sarcura delivers innovative technologies integrated in state-of-the-art GAMP automation to bring cell manufacturing to the next level.
StemSight
StemSight is a cell therapy startup developing novel treatments for blindness operating in Tampere, Finland.
UniteLabs
UniteLabs automates life science labs in minutes instead of days.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-04-07 | Psyber | Psyber acquired by ATAI Life Sciences | N/A |
| 2021-01-12 | Recognify Life Sciences | Recognify Life Sciences acquired by ATAI Life Sciences | N/A |
| 2019-01-03 | Perception Neuroscience | Perception Neuroscience acquired by ATAI Life Sciences | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - ATAI Life Sciences
GrayBella Capital
GrayBella Capital investment in Convertible Note - ATAI Life Sciences
infinitas capital group
infinitas capital group investment in Series D - ATAI Life Sciences
What If Ventures
What If Ventures investment in Series D - ATAI Life Sciences
Alpha Wave Global
Alpha Wave Global investment in Series D - ATAI Life Sciences
Subversive Capital
Subversive Capital investment in Series D - ATAI Life Sciences
Presight Capital
Presight Capital investment in Series D - ATAI Life Sciences
Korify Capital AG
Korify Capital AG investment in Series D - ATAI Life Sciences
Apeiron Investment Group
Apeiron Investment Group investment in Series D - ATAI Life Sciences
Woodline Partners
Woodline Partners investment in Series D - ATAI Life Sciences
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-02-01 | IntelGenX | ATAI Life Sciences investment in Post-IPO Debt - IntelGenX | 3 M USD |
| 2021-03-15 | IntelGenX | ATAI Life Sciences investment in Post-IPO Equity - IntelGenX | 12.35 M USD |
| 2021-03-15 | IntelGenX | ATAI Life Sciences investment in Post-IPO Debt - IntelGenX | 2 M USD |
| 2020-04-27 | COMPASS Pathways | ATAI Life Sciences investment in Series B - COMPASS Pathways | 80 M USD |
| 2019-04-24 | Innoplexus | ATAI Life Sciences investment in Series C - Innoplexus | N/A |